Cornel Medical has been invited to join two EU consortia of leading clinical, industrial and academic partners developing patient monitoring technologies. EU grant applications have been submitted.
Application of optical sensing in POCT
Cornel’s MicroEye(R) microdialysis device is a key factor in enabling therapeutic drug monitoring of immunosuppressants drugs to prevent rejection in transplant patients.